These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 8853261

  • 1. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M, Meuris S, Gohimont AC, Buedts K, Cremer M.
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [Abstract] [Full Text] [Related]

  • 2. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC, Lehman GA, Vasileva G, Malecka-Panas E, Gubergrits N, Shen Y, Sander-Struckmeier S, Caras S.
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of pancreatic insufficiency with a preparation containing high lipase activity].
    Pap A, Szilágyi V, Marosi E.
    Orv Hetil; 1997 Mar 09; 138(10):601-4. PubMed ID: 9157336
    [Abstract] [Full Text] [Related]

  • 4. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
    Gubergrits N, Malecka-Panas E, Lehman GA, Vasileva G, Shen Y, Sander-Struckmeier S, Caras S, Whitcomb DC.
    Aliment Pharmacol Ther; 2011 May 09; 33(10):1152-61. PubMed ID: 21418260
    [Abstract] [Full Text] [Related]

  • 5. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB, Escobar LC, Lees HR, Akroyd RM, Reilly HC.
    N Z Med J; 1992 Mar 25; 105(930):107-8. PubMed ID: 1553114
    [Abstract] [Full Text] [Related]

  • 6. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
    Schneider MU, Knoll-Ruzicka ML, Domschke S, Heptner G, Domschke W.
    Hepatogastroenterology; 1985 Apr 25; 32(2):97-102. PubMed ID: 2408983
    [Abstract] [Full Text] [Related]

  • 7. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK, Rubin J, Harvey J.
    Gastroenterology; 1983 Mar 25; 84(3):476-82. PubMed ID: 6549746
    [Abstract] [Full Text] [Related]

  • 8. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS, Garson JL, Krug SK, Kaul A, Rickard KA, Caffrey HH, Fineberg N, Balistreri WF, Stevens JC.
    J Am Diet Assoc; 2006 Aug 25; 106(8):1181-6. PubMed ID: 16863712
    [Abstract] [Full Text] [Related]

  • 9. [Comparative clinical study of Neopanpur and Creon].
    Beró T, Jávor T.
    Orv Hetil; 1994 Jan 02; 135(1):7-14. PubMed ID: 8290236
    [Abstract] [Full Text] [Related]

  • 10. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG, Lembcke B, Göke B, Creutzfeldt W.
    Z Gastroenterol; 1986 Dec 02; 24(12):753-7. PubMed ID: 3548109
    [Abstract] [Full Text] [Related]

  • 11. Pancreatic enzyme pharmacotherapy.
    Ferrone M, Raimondo M, Scolapio JS.
    Pharmacotherapy; 2007 Jun 02; 27(6):910-20. PubMed ID: 17542772
    [Abstract] [Full Text] [Related]

  • 12. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
    Heijerman HG.
    Neth J Med; 1992 Oct 02; 41(3-4):105-9. PubMed ID: 1470278
    [Abstract] [Full Text] [Related]

  • 13. Replacement therapy in pancreatic insufficiency with a new pancreatin preparation respecting the physiological ratio of lipase/trypsin activity.
    Pap A, Varró V.
    Hepatogastroenterology; 1988 Apr 02; 35(2):83-6. PubMed ID: 3371850
    [Abstract] [Full Text] [Related]

  • 14. Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative study.
    Gouerou H, Dain MP, Parrondo I, Poisson D, Bernades P.
    Int J Pancreatol; 1989 Apr 02; 5 Suppl():45-50. PubMed ID: 2702250
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC, Eisenberg JD, Wagener JS, Ahrens R, Rock M, doPico G, Orenstein DM.
    Am J Gastroenterol; 2000 Aug 02; 95(8):1932-8. PubMed ID: 10950038
    [Abstract] [Full Text] [Related]

  • 16. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ, Gelrud A, Munck A, Caras S.
    Adv Ther; 2010 Dec 02; 27(12):895-916. PubMed ID: 21086085
    [Abstract] [Full Text] [Related]

  • 17. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
    Morrison G, Morrison JM, Redmond AO, Byers CA, McCracken KJ, Dodge JA, Guilford SA, Bowden MW.
    Aliment Pharmacol Ther; 1992 Oct 02; 6(5):549-55. PubMed ID: 1420747
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin].
    Aparisi L, Rodrigo JM, Serra MA, Del Olmo J, Bisquert M, Raga F.
    Rev Esp Enferm Apar Dig; 1989 Jul 02; 76(1):25-30. PubMed ID: 2799034
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.